Cairo-Mubasher: Kahira Pharmaceuticals posted an increase of 5.5% to EGP 43.4 million in net profits for the fiscal year ended July 2015, up from EGP 41.1 million for the previous year.
Earlier, the company released its financial indicators for FY14/15, which showed an increase of 0.9% to EGP 41.49 million in net profits, compared with EGP 41.1 million for the preceding year.
The drug firm's net earnings declined 13% m-o-m in July 2015.
